デフォルト表紙
市場調査レポート
商品コード
1613393

デジタル治療市場:コンポーネント別、用途別-2025-2030年の世界予測

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 194 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.91円
デジタル治療市場:コンポーネント別、用途別-2025-2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタル治療市場は、2023年に64億2,000万米ドルと評価され、2024年には80億5,000万米ドルに達すると予測され、CAGR 26.42%で成長し、2030年には331億6,000万米ドルになると予測されています。

デジタル治療(DTx)とは、身体的、精神的、行動的健康状態を予防、管理、治療するための、高品質なソフトウェアプログラムによるエビデンスに基づく治療介入を指します。DTxが必要とされるのは、ヘルスケアシステムと統合し、患者の転帰の改善、コスト削減、アクセス性の向上に貢献する、個別化されたスケーラブルなソリューションを提供できるからです。これらのソリューションは、さまざまな疾患、特に糖尿病、肥満、心血管疾患、神経疾患などの慢性疾患に応用されており、最終用途には、デジタル・アプリケーションを患者のケア・ワークフローにシームレスに統合できる病院、診療所、在宅ケアの現場が含まれます。市場に影響を与える主な成長要因には、慢性疾患の有病率の上昇、スマートデバイスの普及拡大、接続性の強化、実行可能な治療オプションとしてデジタル治療を認め始めた支持的な規制枠組みなどがあります。COVID-19の大流行は、遠隔患者参加ソリューションの需要を強調し、遠隔医療シナジーを利用する機会を創出し、十分なサービスを受けていない人々へのアクセスを拡大することで、DTxの可能性を浮き彫りにしました。しかし、この市場は、地域によって異なる償還構造や標準化の欠如、潜在的な規制のハードルといった限界に直面しており、普及への課題となっています。AIを活用した個別化治療プログラム、より広範な医療データシステムとの統合プラットフォーム、より良いアドヒアランスとアウトカムを促進するユーザー関与分析の強化といった分野では、今後も技術革新が続くと思われます。企業は、ヘルスケアプロバイダー、保険会社、テクノロジー企業と戦略的パートナーシップを結び、業界横断的なリソースや専門知識を活用することに注力すべきです。有効性を実証するために大規模な臨床試験に投資し、規制当局の確実な承認を得ることは、信頼と受容を得る上で重要です。DTxの市場力学は、ヘルスケア、テクノロジー、コンシューマー・エレクトロニクスの各業界と交差していることを特徴としており、イノベーションと進化するヘルスケア・ニーズへの機敏な対応が求められるダイナミックな環境であることを物語っています。

主な市場の統計
基準年[2023] 64億2,000万米ドル
推定年[2024] 80億5,000万米ドル
予測年[2030] 331億6,000万米ドル
CAGR(%) 26.42%

市場力学:急速に進化するデジタル治療市場の主要市場インサイトを公開

デジタル治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 慢性疾患やライフスタイルに関連した健康問題の増加
    • 遠隔医療と遠隔健康を推進する政府の取り組み
    • ヘルスケアアプリと連動したスマートフォンやタブレットの普及
  • 市場抑制要因
    • 新興経済諸国におけるデジタル治療に関する認知度の低さ
  • 市場機会
    • デジタル治療におけるコンピューティングと人工知能の登場
    • デジタルヘルス事業への資金調達と投資の増加
  • 市場の課題
    • データプライバシーとセキュリティに関する問題

ポーターのファイブフォース:デジタル治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:デジタル治療市場における外部からの影響の把握

外部マクロ環境要因は、デジタル治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析デジタル治療市場における競合情勢の把握

デジタル治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスデジタル治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、デジタル治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨デジタル治療市場における成功への道筋を描く

デジタル治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患や生活習慣に関連する健康問題の発生率の増加
      • 遠隔医療と遠隔診療を促進する政府の取り組み
      • ヘルスケアアプリと組み合わせたスマートフォンやタブレットの導入
    • 抑制要因
      • 新興経済諸国におけるデジタル治療に関する認識の低さ
    • 機会
      • デジタル治療におけるコンピューティングと人工知能の出現
      • デジタルヘルス事業への資金と投資の増加
    • 課題
      • データのプライバシーとセキュリティに関する問題
  • 市場セグメンテーション分析
    • コンポーネント:データ分析ソフトウェアとコンプライアンスサービスの重要性の高まり
    • 応用:糖尿病や慢性呼吸器疾患におけるデジタル治療の採用率の向上、継続的な管理とモニタリングが必要
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 デジタル治療市場:コンポーネント別

  • デバイス
  • ソフトウェアとサービス

第7章 デジタル治療市場:用途別

  • 心血管疾患
  • 中枢神経系障害
  • 慢性呼吸器疾患
  • 糖尿病
  • 服薬遵守
  • 筋骨格障害
  • 肥満
  • 前糖尿病
  • 禁煙

第8章 南北アメリカのデジタル治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のデジタル治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのデジタル治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • BehaVRとFern Healthが合併してRealizedCareを設立、デジタル治療の価値を解き放つデジタルケア管理プラットフォームを立ち上げ
    • ベター・セラピューティクス、2型糖尿病の成人患者を治療するAspyreRxTMの発売を発表
    • Lumanityがデジタル治療アライアンスに参加
  • 戦略分析と提言

企業一覧

  • 2morrow Inc.
  • Akili Interactive Labs, Inc.
  • Ayogo Health Inc.
  • Better Therapeutics, Inc.
  • Big Health, Inc.
  • Biofourmis Inc.
  • Canary Health Technologies Inc.
  • Click Therapeutics, Inc.
  • Cognoa, Inc.
  • DarioHealth Corp.
  • Fern Health, Inc.
  • Fitterfly Healthtech Private Limited
  • Happify, Inc.
  • Headspace Inc.
  • Kaia Health Software Inc.
  • Lark Technologies, Inc.
  • Lumanity Inc.
  • MedRhythms
  • Noom, Inc.
  • Omada Health Inc.
  • Pear Therapeutics, Inc.
  • Propeller Health by ResMed Corp.
  • SilverCloud by American Well Corporation
  • Voluntis by AptarGroup, Inc.
  • Welldoc, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-431752EA4722

The Digital Therapeutics Market was valued at USD 6.42 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 26.42%, to USD 33.16 billion by 2030.

Digital Therapeutics (DTx) refers to evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat physical, mental, and behavioral health conditions. DTx is necessary due to its ability to integrate with healthcare systems to offer personalized and scalable solutions that contribute to improved patient outcomes, reduced costs, and enhanced accessibility. These solutions have applications across a range of diseases, particularly chronic conditions like diabetes, obesity, cardiovascular diseases, and neurological disorders, and the end-use scope includes hospitals, clinics, and home care settings where digital applications can be seamlessly integrated into patient care workflows. Key growth factors influencing the market include a rising prevalence of chronic diseases, increasing adoption of smart devices, enhanced connectivity, and supportive regulatory frameworks which have begun acknowledging digital therapeutics as viable treatment options. The COVID-19 pandemic highlighted the potential of DTx by underscoring the demand for remote patient engagement solutions, creating opportunities to tap into telehealth synergies, and expanding access to underserved populations. However, the market faces limitations such as varying reimbursement structures, a lack of standardization, and potential regulatory hurdles across different regions, which can pose challenges to widespread adoption. Continued innovations are likely in areas such as AI-driven personalized therapeutic programs, integrative platforms with broader health data systems, and enhanced user engagement analytics that foster better adherence and outcomes. Businesses should focus on forming strategic partnerships with healthcare providers, insurance companies, and technology firms to leverage cross-industry resources and expertise. Investing in extensive clinical trials to demonstrate efficacy and obtaining robust regulatory approvals will be instrumental in gaining trust and acceptance. DTx's market nature, characterized by its intersection with healthcare, technology, and consumer electronics industries, underscores a dynamic environment ripe for innovation and agile responses to evolving healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 6.42 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 33.16 billion
CAGR (%) 26.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Therapeutics Market

The Digital Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of chronic diseases and lifestyle-related health issues
    • Government initiatives promoting telehealth and telemedicine
    • Adoption of smartphones and tablets coupled with healthcare apps
  • Market Restraints
    • Limited awareness regarding digital therapeutics in developing economies
  • Market Opportunities
    • Advent of computing and artificial intelligence in digital therapeutics
    • Rising funding and investments for digital health businesses
  • Market Challenges
    • Issues pertaining to data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Digital Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Therapeutics Market

A detailed market share analysis in the Digital Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Therapeutics Market

A strategic analysis of the Digital Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Devices and Software & Services.
  • Based on Application, market is studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
      • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
      • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
      • 5.1.3.2. Rising funding and investments for digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of data analysis software and compliance services
    • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Therapeutics Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Software & Services

7. Digital Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Central Nervous System Disorder
  • 7.4. Chronic Respiratory Disease
  • 7.5. Diabetes
  • 7.6. Medication Adherence
  • 7.7. Musculoskeletal Disorder
  • 7.8. Obesity
  • 7.9. Prediabetes
  • 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
    • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
    • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2morrow Inc.
  • 2. Akili Interactive Labs, Inc.
  • 3. Ayogo Health Inc.
  • 4. Better Therapeutics, Inc.
  • 5. Big Health, Inc.
  • 6. Biofourmis Inc.
  • 7. Canary Health Technologies Inc.
  • 8. Click Therapeutics, Inc.
  • 9. Cognoa, Inc.
  • 10. DarioHealth Corp.
  • 11. Fern Health, Inc.
  • 12. Fitterfly Healthtech Private Limited
  • 13. Happify, Inc.
  • 14. Headspace Inc.
  • 15. Kaia Health Software Inc.
  • 16. Lark Technologies, Inc.
  • 17. Lumanity Inc.
  • 18. MedRhythms
  • 19. Noom, Inc.
  • 20. Omada Health Inc.
  • 21. Pear Therapeutics, Inc.
  • 22. Propeller Health by ResMed Corp.
  • 23. SilverCloud by American Well Corporation
  • 24. Voluntis by AptarGroup, Inc.
  • 25. Welldoc, Inc.